13F HOLDINGS REPORT
Novo Holdings A/S
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001415889-25-021889
Total Value
$1.42B
Positions
29
Other Managers
0
Confidential Omitted
No
Holdings (29)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VANGUARD INDEX FDS | 922908769 | 1,038,550 | $315.6M | 22.28% |
| 2 | BROOKFIELD CORP | 11271J107 | 2,330,830 | $144.2M | 10.18% |
| 3 | ASML HOLDING N V | ASMLF | 165,836 | $132.9M | 9.38% |
| 4 | SALESFORCE INC | CRM | 330,187 | $90.0M | 6.36% |
| 5 | MIRUM PHARMACEUTICALS INC | MIRM | 1,500,055 | $76.3M | 5.39% |
| 6 | EDGEWISE THERAPEUTICS INC | EWTX | 5,350,000 | $70.1M | 4.95% |
| 7 | INSMED INC | INSM | 680,000 | $68.4M | 4.83% |
| 8 | RECURSION PHARMACEUTICALS IN | RXRX | 9,665,128 | $48.9M | 3.45% |
| 9 | CRINETICS PHARMACEUTICALS IN | CRNX | 1,550,000 | $44.6M | 3.15% |
| 10 | ALIBABA GROUP HLDG LTD | BBAAY | 372,327 | $42.2M | 2.98% |
| 11 | ARRIVENT BIOPHARMA INC | AVBP | 1,872,142 | $40.8M | 2.88% |
| 12 | MERUS N V | N5749R100 | 750,000 | $39.5M | 2.78% |
| 13 | BIOMARIN PHARMACEUTICAL INC | BMRN | 660,000 | $36.3M | 2.56% |
| 14 | BLUEPRINT MEDICINES CORP | 09627Y109 | 264,956 | $34.0M | 2.40% |
| 15 | VIRIDIAN THERAPEUTICS INC | VRDN | 2,380,000 | $33.3M | 2.35% |
| 16 | PHARVARIS N V | PHVS | 1,725,000 | $30.4M | 2.14% |
| 17 | VAXCYTE INC | PCVX | 916,160 | $29.8M | 2.10% |
| 18 | CELLDEX THERAPEUTICS INC NEW | CLDX | 1,200,000 | $24.4M | 1.72% |
| 19 | ZENAS BIOPHARMA INC | ZBIO | 2,250,000 | $21.8M | 1.54% |
| 20 | ENLIVEN THERAPEUTICS INC | ELVN | 1,084,432 | $21.8M | 1.54% |
| 21 | APOGEE THERAPEUTICS INC | APGE | 449,392 | $19.5M | 1.38% |
| 22 | CERIBELL INC | CBLL | 900,000 | $16.9M | 1.19% |
| 23 | VALNEVA SE | VALN | 2,375,000 | $13.5M | 0.95% |
| 24 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 2,000,000 | $7.4M | 0.52% |
| 25 | IO BIOTECH INC | IOBT | 3,354,449 | $4.7M | 0.33% |
| 26 | LANZATECH GLOBAL INC | LNZAW | 15,814,845 | $4.3M | 0.30% |
| 27 | MARQETA INC | MQ | 441,558 | $2.6M | 0.18% |
| 28 | ABCELLERA BIOLOGICS INC | ABCL | 652,529 | $2.2M | 0.16% |
| 29 | GALECTO INC | 36322Q206 | 99,913 | $340,703 | 0.02% |